Table 1 Gene Set Enrichment Analysis output for CpGs with high or low MV
Gene set name | NOM p-val | FDR q-val | MV |
|---|---|---|---|
OLFACTORY TRANSDUCTION | 0.000 | 0.000 | High |
GRAFT VERSUS HOST DISEASE | 0.000 | 0.000 | High |
ALLOGRAFT REJECTION | 0.000 | 0.000 | High |
ASTHMA | 0.000 | 0.000 | High |
TYPE I DIABETES MELLITUS | 0.000 | 0.000 | High |
NEUROACTIVE LIGAND RECEPTOR INTERACTION | 0.000 | 0.000 | High |
AUTOIMMUNE THYROID DISEASE | 0.000 | 0.000 | High |
INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION | 0.000 | 0.001 | High |
METABOLISM OF XENOBIOTICS BY CYTOCHROME P450 | 0.000 | 0.018 | High |
ANTIGEN PROCESSING AND PRESENTATION | 0.005 | 0.032 | High |
DRUG METABOLISM CYTOCHROME P450 | 0.004 | 0.035 | High |
CELL ADHESION MOLECULES CAMS | 0.002 | 0.033 | High |
VIRAL MYOCARDITIS | 0.009 | 0.033 | High |
COMPLEMENT AND COAGULATION CASCADES | 0.010 | 0.032 | High |
RETINOL METABOLISM | 0.008 | 0.053 | High |
CYTOKINE CYTOKINE RECEPTOR INTERACTION | 0.001 | 0.052 | High |
SYSTEMIC LUPUS ERYTHEMATOSUS | 0.007 | 0.054 | High |
LEISHMANIA INFECTION | 0.005 | 0.064 | High |
SPLICEOSOME | 0.000 | 0.000 | Low |
RNA DEGRADATION | 0.000 | 0.000 | Low |
HOMOLOGOUS RECOMBINATION | 0.000 | 0.000 | Low |
UBIQUITIN MEDIATED PROTEOLYSIS | 0.000 | 0.000 | Low |
CELL CYCLE | 0.000 | 0.001 | Low |
N-GLYCAN BIOSYNTHESIS | 0.000 | 0.004 | Low |
PARKINSONS DISEASE | 0.000 | 0.006 | Low |
RNA POLYMERASE | 0.003 | 0.007 | Low |
LYSINE DEGRADATION | 0.000 | 0.009 | Low |
HUNTINGTONS DISEASE | 0.000 | 0.013 | Low |
PROTEASOME | 0.004 | 0.018 | Low |
TERPENOID BACKBONE BIOSYNTHESIS | 0.003 | 0.017 | Low |
OXIDATIVE PHOSPHORYLATION | 0.000 | 0.016 | Low |
AMINOACYL TRNA BIOSYNTHESIS | 0.000 | 0.015 | Low |
RIBOSOME | 0.000 | 0.018 | Low |